TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE is a leading peer-reviewed publication dedicated to advancing the frontiers of experimental medicine and biomedical research. Published by TOHOKU UNIV MEDICAL PRESS in Japan, this journal has been a vital source of knowledge for over a century, with its historical span ranging from 1920 to 2024. As a Q2 journal in Biochemistry, Genetics and Molecular Biology and Q3 in Medicine, it boasts an impressive Scopus ranking of 144 out of 636 in General Medicine, thereby signifying its strong influence in the field. The journal aims to disseminate critical findings and innovative research methodologies, fostering a collaborative environment among researchers, clinicians, and students. Despite its traditional publishing model, the journal remains committed to contributing significantly to the global scientific community, ensuring that groundbreaking discoveries and experimental techniques are shared with a wide audience, ultimately enhancing healthcare and therapeutic strategies.

Molecular Pain, published by SAGE Publications Inc, is a leading open access journal dedicated to advancing the field of pain research and management. Since its establishment in 2005, the journal has provided a vital platform for researchers and professionals to share significant findings in anesthesiology and pain medicine, cellular and molecular neuroscience, and molecular medicine. With an impressive impact factor and a strong reputation as evidenced by its Q1 categorization in Anesthesiology and Pain Medicine, this journal ranks among the top resources in its field, positioned in the 79th percentile for Pain Medicine and holding a noteworthy presence within the academic community. The journal’s commitment to disseminating high-quality research underlines its relevance and importance, making it a crucial reference for students, scientists, and clinicians alike. By promoting a deeper understanding of pain mechanisms, Molecular Pain fosters interdisciplinary collaboration and encourages innovative therapeutic approaches, ultimately enhancing patient care and outcomes.

Slovenian Veterinary Research, published by the University of Ljubljana, serves as a significant platform for the dissemination of research within the veterinary field. With an ISSN of 1580-4003 and an E-ISSN of 2385-8761, this open-access journal has made its content freely available to the global research community since 2021, enhancing accessibility and engagement. The journal's scope includes a diverse range of topics relevant to veterinary science, aiming to foster innovation and collaboration among researchers, professionals, and students in the field. Although currently categorized in the Q4 quartile for veterinary studies, the journal is committed to improving its impact and visibility, particularly as it converges on its upcoming years of operation from 2007 to 2024. As it strives to elevate its Scopus ranks, currently positioned at rank #162/194 in General Veterinary, Slovenian Veterinary Research provides a vital resource for advancing knowledge and best practices in veterinary medicine. For anyone interested in the latest veterinary research trends and findings emanating from Slovenia and beyond, this journal represents an essential source of information.

Current Reviews in Clinical and Experimental Pharmacology is a cutting-edge journal published by Bentham Science Publishers in the United Arab Emirates, focusing on the dynamic field of pharmacology. With an ISSN of 2772-4328 and an E-ISSN of 2772-4336, this journal has rapidly established itself as a significant resource for researchers and professionals in the medical and pharmaceutical sciences since its inception in 2021. It boasts an impressive Q3 ranking in Pharmacology (medical) and Q2 in the Pharmacology, Toxicology and Pharmaceutics (miscellaneous) category as of 2023. Furthermore, it ranks #14/80 in general pharmacology, reflecting its esteemed position within the scientific community. As an Open Access publication, it ensures that groundbreaking research is readily accessible, fostering collaboration and innovation. The journal invites high-quality reviews and original articles that address contemporary issues and advancements in clinical and experimental pharmacology, making it an essential venue for disseminating knowledge and engaging with emerging trends in therapeutic developments.

BIOMEDICAL PAPERS-OLOMOUC, published by Palacky University Medical Faculty, is a prominent open-access journal dedicated to advancing the fields of biochemistry, genetics, molecular biology, and general medicine. Since its inception in 2001, this journal has provided a vital platform for researchers, professionals, and students alike, fostering a collaborative environment for the dissemination of cutting-edge research findings. With a current impact factor reflected in its placement in the Q3 quartiles for both biochemistry and medicine categories, it demonstrates a growing influence in the academic community. The journal is indexed in Scopus, showcasing its relevance within the medical and biophysical sciences, and it operates in an open-access format to ensure broad accessibility of its articles. Set against the backdrop of Olomouc, Czech Republic, BIOMEDICAL PAPERS-OLOMOUC continues to contribute significantly to the global dialogue in biomedical research, making it an essential resource for anyone engaged in these dynamic and rapidly evolving fields.

Laboratory Animal Research is a prominent academic journal dedicated to advancing the field of laboratory animal science, providing a platform for researchers, professionals, and students focused on biochemistry, genetics, and molecular biology. Published by SPRINGERNATURE, this journal is recognized for its rigorous peer-review process and commitment to high-quality research, achieving a notable Q2 ranking in the Biochemistry, Genetics and Molecular Biology category as of 2023. Since becoming an Open Access journal in 2015, Laboratory Animal Research has fostered greater accessibility and dissemination of research findings, encouraging collaboration and innovation within the scientific community. With its ISSN 1738-6055 and E-ISSN 2233-7660, the journal is based in the United Kingdom and resides at CAMPUS, 4 Crinan St, London, N1 9XW, England. It is an essential resource for anyone involved in laboratory animal research and strives to enhance the welfare and scientific use of animals in research settings.

FOLIA HISTOCHEMICA ET CYTOBIOLOGICA, an esteemed journal published by VIA MEDICA, serves as a vital platform for researchers and professionals in the fields of histology, pathology, and cytobiology. With an ISSN of 0239-8508 and E-ISSN of 1897-5631, this Open Access journal has been disseminating significant findings since 1984, offering free access to a broad audience of scientists and academics. Based in Poland, this journal focuses on critical advancements in the study of cellular structures and functions, contributing substantially to the understanding of various diseases and biological processes. The journal currently holds a respectable impact factor, ranking in the Q3 category for Histology and miscellaneous Medicine, and Q2 for Pathology and Forensic Medicine as per the 2023 metrics. With its commitment to quality research and an inclusive publishing approach, FOLIA HISTOCHEMICA ET CYTOBIOLOGICA is poised to continue influencing its fields significantly through 2024 and beyond.

INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, published by Wiley, is a leading peer-reviewed journal dedicated to the field of experimental pathology. With an ISSN of 0959-9673 and E-ISSN 1365-2613, the journal has been a vital resource for researchers and professionals since its inception in 1990, covering a broad spectrum of topics within pathology, cell biology, and molecular biology. The journal's relevancy is underscored by its Q2 ranking in Pathology and Forensic Medicine and Q3 rankings in both Cell Biology and Molecular Biology, as of 2023, reflecting its significant contribution to the scientific community. Although it does not currently offer open access options, readers can benefit from its insightful research articles and reviews that guide advancements in diagnostic pathology and therapeutic strategies. As the journal continues to evolve, it remains committed to facilitating the exchange of innovative ideas and findings that drive progress in experimental pathology and related fields, making it an indispensable platform for scientists, clinicians, and students alike.

New Armenian Medical Journal (ISSN: 1829-0825, E-ISSN: 1829-0825) is a prominent academic publication established by Yerevan State Medical University, dedicated to advancing the field of medicine through high-quality research and scholarly discourse. Located in Armenia, this journal serves as a vital platform for disseminating innovative findings and clinical practices, with a particular focus on the regional healthcare landscape as well as global health issues. While currently categorized in the lower quartile (Q4) of general medicine, it demonstrates a commitment to improving its impact factor and ranking, evidenced by its ongoing publication from 2009 to 2024. The journal embraces a diverse scope that encompasses miscellaneous topics within medical research, catering to the needs of practitioners, researchers, and students alike. Though not an open-access journal, it offers valuable insights and knowledge that contribute meaningfully to the medical community. By participating in this scholarly dialogue, readers can enhance their understanding and foster advancements in the ever-evolving field of medicine.

Welcome to Advances in Clinical and Experimental Medicine, an esteemed publication by WROCLAW MEDICAL UNIVERSITY, dedicated to advancing the essential fields of clinical and experimental medicine. With an open access model since 2017, this journal ensures that researchers, healthcare professionals, and students worldwide can freely access high-quality scientific content. Covering a broad spectrum of topics including biochemistry, genetics, internal medicine, and pharmacology, Advances in Clinical and Experimental Medicine has established itself as a pivotal resource in the scientific community, currently holding prestigious rankings such as Q2 in Biochemistry, Genetics, and Molecular Biology (miscellaneous) and Q1 in Reviews and References (medical) for 2023. Spanning over two decades of rigorous research publication, the journal is a critical platform for sharing innovative findings and fostering collaboration among scholars, making it an invaluable asset for those at the forefront of medical science.